Preclinical Evidence of Nanomedicine Formulation to Target Mycobacterium tuberculosis at Its Bone Marrow Niche

One-third of the world’s population is estimated to be latently infected with Mycobacterium tuberculosis (Mtb). Recently, we found that dormant Mtb hides in bone marrow mesenchymal stem cells (BM-MSCs) post-chemotherapy in mice model and in clinical subjects. It is known that residual Mtb post-chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garhyan, Jaishree, Mohan, Surender, Rajendran, Vinoth, Bhatnagar, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281663/
https://www.ncbi.nlm.nih.gov/pubmed/32414000
http://dx.doi.org/10.3390/pathogens9050372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281663/
https://www.ncbi.nlm.nih.gov/pubmed/32414000
http://dx.doi.org/10.3390/pathogens9050372

Ejemplares similares